Expression of osteopontin in cisplatin-induced tubular injury

Nephron - Experimental Nephrology

Volumn 97, Issue 3, 2004, Pages

  Iguchi, Seitaro ^a,b,c   Nishi, Shinichi ^a   Ikegame, Mika ^b,c   Hoshi, Kazuto ^b   Yoshizawa, Tatsuya ^c   Kawashima, Hiroyuki ^c   Arakawa, Masaaki ^a   Ozawa, Hidehiro ^b   Gejyo, Fumitake ^a  

^a Div Clin Nephrology Rheumatology   (Japan)

^b Anat Cell Biol of the Hard Tissue   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Cisplatin; Osteopontin; Tubular injury

Indexed keywords

CISPLATIN; HERMES ANTIGEN; MESSENGER RNA; OSTEOPONTIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CORTEX; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; ANIMAL CELL; CELL INTERACTION; KIDNEY CORTEX NECROSIS; KIDNEY EPITHELIUM;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CISPLATIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY TUBULES; MALE; OSTEOPONTIN; RATS; RATS, WISTAR; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 4043086986     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078643     Document Type: Article

References (21)

1. Franzen A, Heinegard D: Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985;232:715-724.
2. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE: Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 1987;262:2900-2907.
3. Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT: Heterogenity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 1993;69:355-363.
4. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-524.
5. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 1994;144:915-926.
6. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:2377-2383.
7. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 1993;268:15180-15184.
8. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T: Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 1995;55:6-10.
9. Rollo EE, Laskin DL, Denhardt DT: Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukocyte Biol 1996;60:397-404.
10. Rollo EE, Denhardt DT: Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 1996;88:642-647.
11. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993;92:2814-2820.
12. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF: Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 1997;77:103-108.
13. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ: Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998;54:416-425.
14. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, Goligorsky MS: Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 1999;56:74-82.
15. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL: Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998;101:1468-1478.
16. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H: Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 2000;4:260-264.
17. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;26:509-512.
18. Oertli B, Fan X, Wüthrich RP: Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrol Dial Transplant 1998;13:271-278.
19. Persy VP, Verstrepen WA, Ysebaert DK, De Greef KE, De Broe ME: Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. Kidney Int 1999;56:601-611.
20. Yuansheng XS, Shinichi N, Seitaro I, Naofumi I, Minoru S, Akihiko S, Mika I, Noriaki I, Hisaki S, Mitsuhiro U, Hiroyuki K, Masaaki A, Fumitake G: Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. Kidney Int 2001;59:959-974.
21. Goligorsky MS, Noiri E, Kessler H, Romanov V: Therapeutic potential of RGD peptides in acute renal injury. Kidney Int 1997;51:1487-1492.